SYNTHESIS AND ANTIVIRAL ACTIVITY OF VARIOUS 3'-AZIDO ANALOGS OF PYRIMIDINE DEOXYRIBONUCLEOSIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS (HIV-1, HTLV-III-LAV)

被引:139
|
作者
LIN, TS
GUO, JY
SCHINAZI, RF
CHU, CK
XIANG, JN
PRUSOFF, WH
机构
[1] YALE UNIV,SCH MED,CTR COMPREHENS CANC,NEW HAVEN,CT 06510
[2] EMORY UNIV,SCH MED,DEPT PEDIAT,ATLANTA,GA 30303
[3] UNIV GEORGIA,COLL PHARM,ATHENS,GA 30602
[4] VET ADM MED CTR,ATLANTA,GA
关键词
D O I
10.1021/jm00397a011
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:336 / 340
页数:5
相关论文
共 50 条
  • [21] Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infection
    Kaplan, SS
    Hicks, CB
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (02) : 273 - 276
  • [22] Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1
    Pery, Erez
    Sheehy, Ann
    Nebane, N. Miranda
    Misra, Vikas
    Mankowski, Marie K.
    Rasmussen, Lynn
    White, E. Lucile
    Ptak, Roger G.
    Gabuzda, Dana
    VIROLOGY, 2015, 484 : 276 - 287
  • [23] In Vitro and In Silico Antiviral Activity of Di-Halogenated Compounds Derived from L-Tyrosine against Human Immunodeficiency Virus 1 (HIV-1)
    Serna-Arbelaez, Maria S.
    Garcia-Carcamo, Valentina
    Rincon-Tabares, Daniel S.
    Guerra, Diego
    Loaiza-Cano, Vanessa
    Martinez-Gutierrez, Marlen
    Pereanez, Jaime A.
    Pastrana-Restrepo, Manuel
    Galeano, Elkin
    Zapata, Wildeman
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (10) : 8173 - 8200
  • [24] In vitro and in silico antiviral activity of di-halogenated compounds derived from L-tyrosine against Human Immunodeficiency Virus1 (HIV-1)
    Serna-Arbelaez, Maria S.
    Loaiza-Cano, Vanessa
    Martinez-Gutierrez, Marlen
    Pereanez, Jaime A.
    Galeano, Elkin
    Zapata, Wildeman
    IATREIA, 2022, 35 : S33 - S34
  • [25] REVERSE TRANSCRIPTASES FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1), HIV-2, AND SIMIAN IMMUNODEFICIENCY VIRUS (SIVMAC) ARE SUSCEPTIBLE TO INHIBITION BY FOSCARNET AND 3'-AZIDO-3'-DEOXYTHYMIDINE TRIPHOSPHATE
    VRANG, L
    OBERG, B
    LOWER, J
    KURTH, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) : 1733 - 1734
  • [26] SYNTHESIS AND ANTIVIRAL ACTIVITY OF SEVERAL 2,5'-ANHYDRO ANALOGS OF AZT, 3'-AZIDO-2',3'-DIDEOXYURIDINE (AZU),3'- AZIDO-2',3'-DIDEOXY-5-HALOURIDINES, AND 3'-DEOXYTHYMIDINE AGAINST HIV-1 AND R-MULV
    LIN, TS
    SHEN, ZY
    AUGUST, ME
    PRUSOFF, WH
    BRANKOVAN, V
    YANG, HY
    GHAZZOULI, I
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 197 : 30 - CARB
  • [27] Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors
    Randolph, John T.
    Huang, Peggy P.
    Flosi, William J.
    DeGoey, David
    Klein, Larry L.
    Yeung, Clinton M.
    Flentge, Charles
    Sun, Mingua
    Zhao, Chen
    Dekhtyar, Tatyana
    Mo, Hongmei
    Colletti, Lynn
    Kati, Warren
    Marsh, Kennan C.
    Molla, Akhteruzzaman
    Kempf, Dale J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (12) : 4035 - 4046
  • [28] Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo
    Poirier M.C.
    Olivero O.A.
    Hardy A.W.
    Franchini G.
    Borojerdi J.P.
    Walker V.E.
    Walker D.M.
    Shearer G.M.
    AIDS Research and Therapy, 6 (1)
  • [29] Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus
    Chong, Huihui
    Zhu, Yuanmei
    Yu, Danwei
    He, Yuxian
    JOURNAL OF VIROLOGY, 2018, 92 (20)
  • [30] SYNTHESIS AND BIOLOGICAL EVALUATION OF 2',3'-DIDEOXY-L-PYRIMIDINE NUCLEOSIDES AS POTENTIAL ANTIVIRAL AGENTS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) AND HEPATITIS-B VIRUS (HBV)
    LIN, TS
    LUO, MZ
    LIU, MC
    PAI, SB
    DUTSCHMAN, GE
    CHENG, YC
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (06) : 798 - 803